{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:27:07Z","timestamp":1770985627434,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003195","name":"Dutch Ministry of Economic Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003195","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.07.051","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T04:30:21Z","timestamp":1406262621000},"page":"5323-5329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen"],"prefix":"10.1016","volume":"32","author":[{"given":"N.","family":"Oreshkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.H.M.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.M.","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.M.","family":"Moormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kortekaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.07.051_bib0005","first-page":"555","article-title":"Replicon-based vectors of positive strand RNA viruses","volume":"2","author":"Khromykh","year":"2000","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1466252312000011","article-title":"Alphavirus replicon vaccines","volume":"13","author":"Vander Veen","year":"2012","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/v2020413","article-title":"RNA replicons \u2013 a new approach for influenza virus immunoprophylaxis","volume":"2","author":"Zimmer","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0020","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1128\/JVI.78.12.6271-6281.2004","article-title":"RNA recombination in vivo in the absence of viral replication","volume":"78","author":"Gallei","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0025","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1128\/JVI.69.12.7391-7401.1995","article-title":"Genesis of Sindbis virus by in vivo recombination of nonreplicative RNA precursors","volume":"69","author":"Raju","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/MMBR.56.1.61-79.1992","article-title":"RNA recombination in animal and plant viruses","volume":"56","author":"Lai","year":"1992","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0035","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1099\/vir.0.19277-0","article-title":"Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses","volume":"84","author":"Chare","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0040","doi-asserted-by":"crossref","first-page":"11201","DOI":"10.1128\/JVI.77.20.11201-11211.2003","article-title":"Genetic recombination during coinfection of two mutants of human respiratory syncytial virus","volume":"77","author":"Spann","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0045","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1128\/JVI.79.21.13231-13238.2005","article-title":"A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector","volume":"79","author":"Publicover","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0050","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1128\/JVI.00841-11","article-title":"Creation of a nonspreading Rift Valley fever virus","volume":"85","author":"Kortekaas","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0055","series-title":"The Bunyaviridae","author":"Elliott","year":"1996"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0060","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/JVI.62.3.826-833.1988","article-title":"Rift-Valley fever virus M segment \u2013 use of recombinant vaccinia viruses to study Phlebovirus gene-expression","volume":"62","author":"Kakach","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0042-6822(84)90277-0","article-title":"Protein-synthesis in Rift-Valley fever virus-infected cells","volume":"134","author":"Struthers","year":"1984","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0070","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","volume":"81","author":"Won","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0075","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0080","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription","volume":"78","author":"Billecocq","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0085","first-page":"243","article-title":"Recombinant vectors as influenza vaccines","volume":"333","author":"Kopecky-Bromberg","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0090","doi-asserted-by":"crossref","first-page":"e44447","DOI":"10.1371\/journal.pone.0044447","article-title":"Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice","volume":"7","author":"Cornelissen","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1177127","article-title":"Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets","volume":"325","author":"Munster","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0100","first-page":"10","article-title":"Rapid emergence of a virulent PB2 E627K variant during adaptation of highly pathogenic avian influenza H7N7 virus to mice","author":"de Jong","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0105","doi-asserted-by":"crossref","first-page":"e77461","DOI":"10.1371\/journal.pone.0077461","article-title":"A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs","volume":"8","author":"Oreshkova","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0110","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jmb.2004.02.020","article-title":"Very fast folding and association of a trimerization domain from bacteriophage T4 fibritin","volume":"337","author":"Guthe","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2010.03.047","article-title":"The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity","volume":"403","author":"de Vries","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0125","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1128\/JVI.72.11.9404-9406.1998","article-title":"Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones","volume":"72","author":"Tamura","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0130","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/sj.gt.3301335","article-title":"Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB\/c mice: identification of an H2-Kd-restricted CTL epitope","volume":"7","author":"Gambotto","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/infdis\/jir354","article-title":"Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine","volume":"204","author":"Morrill","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0140","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0145","first-page":"5","article-title":"Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin","author":"Weldon","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0150","doi-asserted-by":"crossref","first-page":"e10645","DOI":"10.1371\/journal.pone.0010645","article-title":"A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1","volume":"5","author":"Cornelissen","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0155","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.vaccine.2010.12.096","article-title":"Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus","volume":"29","author":"Loeffen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/jir249","article-title":"Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus","volume":"204","author":"Morrill","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0165","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/JVI.06190-11","article-title":"Development of a novel nonhuman primate model for Rift Valley fever","volume":"86","author":"Smith","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0170","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/IAI.33.3.848-853.1981","article-title":"Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus","volume":"33","author":"Brown","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.07.051_bib0175","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0035-9203(79)90005-1","article-title":"The Rift Valley fever epizootic in Egypt 1977\u201378. 2. Ecological and entomological studies","volume":"73","author":"Hoogstraal","year":"1979","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T15:49:02Z","timestamp":1598111342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14009943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":35,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14009943"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}